Full Valeant Pharma (VRX) Presentation from Today's JPMorgan Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall St gains as chips recover; megacap earnings in focus
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Wall St gains as chips recover; megacap earnings in focus
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- IREN raises 2026 revenue target to $4bn after $2.8bn in contracts
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Valeant Pharma (VRX) Confirms FY16 Guidance at Investor Meeting
January 13, 2016 1:55 PM ESTValeant Pharma (NYSE: VRX) Confirms FY16 Guidance at Investor Meeting
... MoreValeant Pharma (VRX) CEO's family said Pearson timetable to return uncertain - Bloomberg
January 13, 2016 1:40 PM ESTValeant Pharma (NYSE: VRX) CEO's family said Pearson timetable to return uncertain - Bloomberg. Comments were made by the interim CEO at today's investor conference.
... More